Fayetteville Arkansas Hospital Company, LLC. v. Amneal Pharmaceuticals, LLC.et al

CourtDistrict Court, W.D. Arkansas
DecidedMay 18, 2020
Docket5:20-cv-05036
StatusUnknown

This text of Fayetteville Arkansas Hospital Company, LLC. v. Amneal Pharmaceuticals, LLC.et al (Fayetteville Arkansas Hospital Company, LLC. v. Amneal Pharmaceuticals, LLC.et al) is published on Counsel Stack Legal Research, covering District Court, W.D. Arkansas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Fayetteville Arkansas Hospital Company, LLC. v. Amneal Pharmaceuticals, LLC.et al, (W.D. Ark. 2020).

Opinion

IN THE UNITED STATES DISTRICT COURT WESTERN DISTRICT OF ARKANSAS FAYETTEVILLE DIVISION

FAYETTEVILLE ARKANSAS HOSPITAL COMPANY, LLC, et al. PLAINTIFFS

V. CASE NO. 5:20-CV-5036

AMNEAL PHARMACEUTICALS, LLC, et al. DEFENDANTS

OPINION AND ORDER

Before the Court are two ripe motions: Plaintiffs have filed a motion seeking remand of this action to state court (Doc. 17), and separate Defendants Cardinal Health, Walgreens Boots Alliance, Inc., Walgreen Co., Walgreen Eastern Co., Inc., and CVS Pharmacy, Inc. (collectively, “moving Defendants”) request that the Court stay its proceedings pending a final decision by the Judicial Panel on Multidistrict Litigation (“JPML”) whether to transfer the action to multidistrict litigation (“MDL”). (Doc. 36). Having considered all relevant materials,1 the Court GRANTS Plaintiffs’ Motion to Remand (Doc. 17) and DENIES moving Defendants’ Motion to Stay (Doc. 36) for the reasons discussed below. I. BACKGROUND Plaintiffs originally filed their complaint in the Circuit Court of Washington County, Arkansas. The amended complaint makes six claims for relief: 1) Violations of the Arkansas Deceptive Trade Practices Act; 2) Negligence; 3) Nuisance; 4) Unjust

1 Plaintiffs filed a Memorandum Brief in Support of their Motion to Remand (Doc. 18). Cardinal Health filed a Response in Opposition (Doc. 35), and Plaintiffs filed a Reply (Doc. 42). Plaintiffs also filed a Response in Opposition to moving Defendants’ Motion to Stay (Doc. 43). Enrichment; 5) Fraud and Deceit; and 6) Civil Conspiracy. These claims arise out of Defendants’ alleged involvement in the nationwide opioid crisis, and more specifically Defendants’ conduct as it relates to Arkansas. See Doc. 3. Defendant Cardinal Health, Inc. (“Cardinal”), with the consent of the other

defendants, removed the action to this Court. In its Notice of Removal (Doc. 1), Cardinal argues that federal jurisdiction is proper pursuant to 28 U.S.C. §§ 1441 and 1331 because Plaintiffs’ claims arise under federal law. Specifically, Cardinal argues that Defendants’ liability, as alleged by Plaintiffs, arises out of violations of a federal statute, the Controlled Substances Act, 21 U.S.C. §§ 801 et seq., and its implementing regulations. After removing the case to federal court, Cardinal also filed a notice with the JPML seeking transfer to MDL No. 2804, In re National Prescription Opiate Litigation, in the Northern District of Ohio. The JPML issued a conditional transfer order based on its assessment that this case “involve[s] questions of fact that are common to the actions previously transferred” to the MDL. (Doc. 36-1, Exh. 3).

Plaintiffs then filed an Emergency Motion to Remand, arguing that the federal court lacked subject-matter jurisdiction and seeking to have the case remanded before a final decision by the JPML whether to transfer the matter to the opioid MDL. Moving Defendants, in turn, filed a Motion to Stay, urging this Court to stay its proceedings until the JPML made its final decision regarding transfer, since the case was likely to be transferred, and Plaintiffs’ Motion to Remand is best addressed by the MDL. II. DISCUSSION The Court finds it appropriate to take up first Plaintiffs’ Motion to Remand. “It is axiomatic that a court may not proceed at all in a case unless it has jurisdiction.” Crawford v. F. Hoffman-La Roche Ltd., 267 F.3d 760, 764 (8th Cir. 2001) (citing Ex Parte McCardle, 7 Wall. 506, 514 (1868)). “Jurisdiction is power to declare the law, and when it ceases to exist, the only function remaining to the court is that of announcing the fact and dismissing the cause.” Ex Parte McCardle, 7 Wall. 506, 514 (1868). “[A] court has a special obligation

to consider whether it has subject matter jurisdiction in every case [including] the concomitant responsibility to consider sua sponte the court's subject matter jurisdiction where the court believes that jurisdiction may be lacking.” Hart v. United States, 630 F.3d 1085, 1089 (8th Cir. 2011) (quoting Clark v. Baka, 593 F.3d 712, 714 (8th Cir. 2010) (per curiam)) (internal quotations and citations omitted, and modifications adopted). Because of the singular importance of acting only within the scope of its subject-matter jurisdiction, the Court finds it appropriate to consider the merits of the Motion to Remand before turning to Defendants’ Motion to Stay. This is similar to the reasoning of the district court in Meyers v. Bayer AG, 143 F. Supp. 2d 1044, 1048–49 (E.D. Wisc. 2001), which this Court finds persuasive. The court

in Meyers recognized that the court’s power to stay proceedings “is incidental to the power inherent in every court to control the disposition of the causes on its docket with economy of time and effort for itself, for counsel, and for litigants.” Landis v. North American Co., 299 U.S. 248, 254 (1936). See also Clinton v. Jones, 520 U.S. 681, 706 (1997) (“The District Court has broad discretion to stay proceedings as an incident to its power to control its own docket.”). Nevertheless, based on its understanding of the primacy of subject-matter jurisdiction, the Meyers court concluded that “a court's first step should be to make a preliminary assessment of the jurisdictional issue.” Id. at 1048. “If this preliminary assessment suggests that removal was improper, the court should promptly complete its consideration and remand the case to state court.” Id. at 1049. But if the issue of the court’s subject-matter jurisdiction “appears factually or legally difficult, the court’s second step should be to determine whether identical or similar jurisdictional issues have been raised in other cases that have been or may be transferred to the MDL

proceeding” such that allowing the MDL to decide the jurisdictional issue would “further judicial economy and consistency.” Id. “Only if the jurisdictional issue is both difficult and similar or identical to those in cases transferred or likely to be transferred should the court proceed to the third step and consider the motion to stay.” Id. In deciding whether to stay proceedings pending a potential transfer to an MDL in such a context, the Court should consider (1) the potential prejudice to the non-moving party; (2) the hardship and inequity to the moving party; and (3) the interests of judicial economy and efficiency. See id.; Rivers v. Walt Disney Co., 980 F. Supp. 1358, 1360 (C.D. Cal. 1997); Adams v. Tyson Foods, Inc., 2007 WL 1539325, at *1 (W.D. Ark. May 25, 2007).

A. Motion to Remand An action may be removed from state to federal court if it is one in which district courts would have original jurisdiction. 28 U.S.C. § 1441(a). This includes actions in which the claim arises under the Constitution, laws, or treaties of the United States, known as federal question jurisdiction. See 28 U.S.C. §§ 1441(c)(1)(A) & 1331.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ex Parte McCardle
74 U.S. 506 (Supreme Court, 1869)
Landis v. North American Co.
299 U.S. 248 (Supreme Court, 1936)
Clinton v. Jones
520 U.S. 681 (Supreme Court, 1997)
Hart v. United States
630 F.3d 1085 (Eighth Circuit, 2011)
Crawford v. Hoffman-La Roche Ltd.
267 F.3d 760 (Eighth Circuit, 2001)
Gunn v. Minton
133 S. Ct. 1059 (Supreme Court, 2013)
Clark v. Baka
593 F.3d 712 (Eighth Circuit, 2010)
Rivers v. Walt Disney Co.
980 F. Supp. 1358 (C.D. California, 1997)
Meyers v. Bayer AG
143 F. Supp. 2d 1044 (E.D. Wisconsin, 2001)
David Zink v. George Lombardi
783 F.3d 1089 (Eighth Circuit, 2015)
Dunaway v. Purdue Pharma L.P.
391 F. Supp. 3d 802 (M.D. Tennessee, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
Fayetteville Arkansas Hospital Company, LLC. v. Amneal Pharmaceuticals, LLC.et al, Counsel Stack Legal Research, https://law.counselstack.com/opinion/fayetteville-arkansas-hospital-company-llc-v-amneal-pharmaceuticals-arwd-2020.